Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04099836
Title Atezolizumab and Bevacizumab in Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer in Patients With Progressive Disease After Receiving Osimertinib
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Duke University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.